No Data
No Data
Corvus Stock Up on Initiation of Phase III Lymphoma Study on Lead Drug
Corvus Spikes as Late-stage Trial for Lead Asset Announced
Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial Of Soquelitinib For Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
Express News | Corvus Pharmaceuticals Inc - Trial to Enroll Patients at 40 Sites in US, Canada, Australia, South Korea
Express News | Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
No Data
No Data